Kim Drapkin is an accomplished financial executive and board member with extensive experience in the biotechnology sector. Currently serving as Chairperson of the Board at Lucy Therapeutics and as a board member at LENZ Therapeutics, Acumen Pharmaceuticals, Kineta, and Imugene Limited, Drapkin plays a crucial role in various committees, including audit and compensation. Previously, Drapkin was Chief Executive Officer of Graphite Bio and Chief Financial Officer at Jounce Therapeutics, where successful leadership resulted in a notable IPO. With a background in financial consulting and a strong educational foundation from Babson College and Harvard Business School, Drapkin has contributed significantly to the governance and financial oversight of multiple organizations in the biotech industry.
This person is not in the org chart
This person is not in any teams